Changes

It worked. (They also found PPE worked.)

It worked. (They also found PPE worked.)

{{Compared to controls, cases were slightly older (34.7 vs. 33.5 yr) and had more males (58 vs. 50%). In multivariate analyses, HCWs performing endotracheal intubation had higher odds of being SARS-CoV-2 infected [adjusted odds ratio (AOR): 4.33, 95% confidence interval (CI): 1.16-16.07]. Consumption of four or more maintenance doses of HCQ was associated with a significant decline in the odds of getting infected (AOR: 0.44; 95% CI: 0.22-0.88); a dose-response relationship existed between frequency of exposure to HCQ and such reductions (χ[2] for trend=48.88; P <0.001). In addition, the use of PPE was independently associated with the reduction in odds of getting infected with SARS-CoV-2.</nowiki><ref name=Indiastud>[https://pubmed.ncbi.nlm.nih.gov/32611916/ Healthcare workers & SARS-CoV-2 infection in India: A case-control investigation in the time of COVID-19] by Pranab Chatterjee (2020 May) ''The Indian Journal of Medical Research''</ref>}}  AOR stands for adjusted odds ratio and it represents how likely a certain outcome will occur given exposure to the variable of interest.  In this case, the outcome is SARS-CoV-2 infected and the variable of interest is the use of HCQ.  Odds ratios above 1 mean that that outcome is more likely to occur given exposure to the variable.  In the above results, "Performing endotracheal intubation" was associated with a high likelihood of being SARS-CoV-2 infected (4.33).  Odds rations that are below 1 mean that the outcome is less likely to occur.  In the above results, "4 or more maintenance doses of HCQ" was associated with a significant decline in the odds of health care workers becoming SARS-Cov-2 infected (0.44).  This means that people who took HCQ were about half as likely to become infected than those who didn't take the drug (the confidence interval ranged from .22 to .88).  India's researchers also found that HCQ's dose-response relationship had statistical significance (P <0.001).<ref name=Indiastud/><ref name=CBoul/>

{{quotebox|<nowiki>Compared to controls, cases were slightly older (34.7 vs. 33.5 yr) and had more males (58 vs. 50%). In multivariate analyses, HCWs performing endotracheal intubation had higher odds of being SARS-CoV-2 infected [adjusted odds ratio (AOR): 4.33, 95% confidence interval (CI): 1.16-16.07]. Consumption of four or more maintenance doses of HCQ was associated with a significant decline in the odds of getting infected (AOR: 0.44; 95% CI: 0.22-0.88); a dose-response relationship existed between frequency of exposure to HCQ and such reductions (χ[2] for trend=48.88; P <0.001). In addition, the use of PPE was independently associated with the reduction in odds of getting infected with SARS-CoV-2.</nowiki><ref name=Indiastud>[https://pubmed.ncbi.nlm.nih.gov/32611916/ Healthcare workers & SARS-CoV-2 infection in India: A case-control investigation in the time of COVID-19] by Pranab Chatterjee (2020 May) ''The Indian Journal of Medical Research''</ref>}}  AOR stands for adjusted odds ratio and it represents how likely a certain outcome will occur given exposure to the variable of interest.  In this case, the outcome is SARS-CoV-2 infected and the variable of interest is the use of HCQ.  Odds ratios above 1 mean that that outcome is more likely to occur given exposure to the variable.  In the above results, "Performing endotracheal intubation" was associated with a high likelihood of being SARS-CoV-2 infected (4.33).  Odds rations that are below 1 mean that the outcome is less likely to occur.  In the above results, "4 or more maintenance doses of HCQ" was associated with a significant decline in the odds of health care workers becoming SARS-Cov-2 infected (0.44).  This means that people who took HCQ were about half as likely to become infected than those who didn't take the drug (the confidence interval ranged from .22 to .88).  India's researchers also found that HCQ's dose-response relationship had statistical significance (P <0.001).<ref name=Indiastud/><ref name=CBoul/>

===Other Studies===

===Other Studies===